LIXT Market Structure

Lixte Biotechnology Holdings, Inc. (LIXT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $89.1M, listed on NASDAQ, employing roughly 3 people, carrying a beta of 1.25 to the broader market. Lixte Biotechnology Holdings, Inc. Led by Geordan G. Pursglove, public since 2007-10-25.

Market structure data reveals where a stock trades across exchanges, dark pools, and alternative trading systems. Understanding off-exchange activity helps identify institutional trading patterns and liquidity dynamics.

Latest Week Ending

2026-06-08

Weekly OTC Shares

444.0K

Weekly OTC Trades

4.1K

12-Week Total Shares

2.3M

Avg Trade Size (12-Week)

50 shares

How Single-Name Off-Exchange Volume Affects Options

For single-name equities, persistent off-exchange volume concentrations can flag institutional positioning - large blocks arranged through ATS venues to avoid lit-market impact, or correlation-arbitrage flow from sector rotation. The flow doesn't directly move the lit-market price (it prints at the ATS) but it changes the inventory position of the institutional counterparty, which then drives subsequent lit-market flow. Compare the off-exchange volume series above with LIXT's gamma exposure and options volume history to see whether unusual dark-pool activity coincides with rebalancing in the options book.

Showing 12 weeks of off-exchange trading data for Lixte Biotechnology Holdings, Inc..

Learn how market structure is reported and how to read the data →